{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-030523","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2022-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.012026+00:00","generated_at":"2026-06-21T15:09:24.747620+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Privia Health selling stockholders complete 5.75M share secondary offering, no proceeds to company","bullets":["Selling stockholders sold 5,000,000 firm shares plus 750,000 option shares (total 5.75M) in underwritten public offering.","Company received no proceeds from the secondary sale; all shares sold by existing stockholders.","Underwriting agreement with Goldman Sachs & Co. LLC included customary representations and indemnification.","Offering closed on November 21, 2022; 30-day underwriter option exercised in full on November 18."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-030523","json":"https://secwatch.observer/filing/0001628280-22-030523.json","markdown":"https://secwatch.observer/filing/0001628280-22-030523.md","text":"https://secwatch.observer/filing/0001628280-22-030523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/0001628280-22-030523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/prva-20221116.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T15:09:24.747620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5576832f762fa1bf1bce398a44b4d14a230fe1a0","claim":"Privia Health Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC valued at 5,000,000 shares of common stock (plus up to 750,000 additional shares over-allotment) (effective 2022-11-16).","evidence_excerpt":"On November 16, 2022, Privia Health Group, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, in its capacity as the representative of the several underwriters listed on Schedule I thereto (in such capacity, the “Representative”) and the selling stockholders listed on Schedule II thereto (the “Selling Stockholders”) with respect to an underwritten offering by the Selling Stockholders of 5,000,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), held by such Selling Stockholders. In addition, the underwriters were granted a 30-day option to purchase up to 750,000 additional shares (the “Optional Shares” and, together with the Firm Shares, the “Shares”) of Common Stock from the Selling Stockholders at the public offering price, less underwriting discounts and commissions, which the underwriters exercised in full on November 18, 2022.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/0001628280-22-030523-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Goldman Sachs & Co. LLC"},{"label":"Value","value":"5,000,000 shares of common stock (plus up to 750,000 additional shares over-allotment)"},{"label":"Effective","value":"2022-11-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}